Myeloid-derived suppressor cells (MDSCs) have been shown to control self-reactive and anti-graft effector T-cells in autoimmunity and transplantation, but their therapeutic use is limited by their scarce availability in the peripheral blood of tumor-free donors. We isolated and characterized a novel population of myeloid suppressor cells, named fibrocytic MDSC (f-MDSC), which are differentiated from umbilical cord blood (UCB) precursors (Zoso et al., 2014). This MDSC subset promotes regulatory T-cell expansion and induces normoglycemia in a xenogeneic model of type 1 diabetes. Here we describe in details the experimental design and the bioinformatics analyses of the gene expression dataset used to investigate the molecular mechanisms at the base of MDSC tolerogenic and suppressive properties. We also provide an R code to easily access the data and perform the quality controls and basic analyses relevant to this dataset. Raw and pre-processed data are available at Gene Expression Omnibus under accession GSE52376.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535898PMC
http://dx.doi.org/10.1016/j.gdata.2014.10.018DOI Listing

Publication Analysis

Top Keywords

gene expression
12
suppressor cells
12
myeloid-derived suppressor
8
expression profiling
4
profiling human
4
human fibrocytic
4
fibrocytic myeloid-derived
4
cells f-mdscs
4
f-mdscs myeloid-derived
4
cells mdscs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!